$4.92
2.63114.85%
In chiusura: Sep 24, 5:00 PM EST
$5.72
0.8016.22%
Post-mercato: 7:59 PM EST

Apimeds Pharmaceuticals (APUS) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | — | — | — | — |
| Actual | $-11.77 | $-22.60 | $-8.00 | $-14.00 |
| Surprise | — | — | — | — |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |